Skip to content

Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage.

CPQCC Publication
TitleNeurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage.
Publication TypeJournal Article
Year of Publication2013
AuthorsPayne AH, Hintz SR, Hibbs AMaria, Walsh MC, Vohr BR, Bann CM, Wilson-Costello DE
Corporate AuthorsEunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
JournalJAMA Pediatr
Volume167
Issue5
Pagination451-9
Date Published2013 May
ISSN2168-6211
KeywordsAdult, Cerebral Palsy, Child, Preschool, Cognition Disorders, Developmental Disabilities, Echoencephalography, Female, Humans, Infant, Infant, Extremely Premature, Infant, Newborn, Intracranial Hemorrhages, Language Development Disorders, Longitudinal Studies, Male, Motor Skills Disorders, Multivariate Analysis, Risk, Risk Factors, United States
Abstract

IMPORTANCE: Low-grade periventricular-intraventricular hemorrhage is a common neurologic morbidity among extremely low-gestational-age neonates, yet the outcomes associated with this morbidity are not fully understood. In a contemporary multicenter cohort, we evaluated the impact of such hemorrhages on early (18-22 month) neurodevelopmental outcomes of extremely premature infants.

OBJECTIVE: To compare neurodevelopmental outcomes at 18 to 22 months' corrected age for extremely low-gestational-age infants with low-grade (grade 1 or 2) periventricular-intraventricular hemorrhage with those of infants with either no hemorrhage or severe (grade 3 or 4) hemorrhage demonstrated on cranial ultrasonography.

DESIGN: Longitudinal observational study.

SETTING: Sixteen centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

PARTICIPANTS: A total of 1472 infants born at less than 27 weeks' gestational age between January 1, 2006, and December 31, 2008, with ultrasonography results within the first 28 days of life and surviving to 18 to 22 months with complete follow-up assessments were eligible.

MAIN EXPOSURE: Low-grade periventricular-intraventricular hemorrhage.

MAIN OUTCOME MEASURES: Outcomes included cerebral palsy; gross motor functional limitation; cognitive and language scores according to the Bayley Scales of Infant Development, 3rd Edition; and composite measures of neurodevelopmental impairment. Regression modeling evaluated the association of hemorrhage severity with adverse outcomes while controlling for potentially confounding variables and center differences.

RESULTS: Low-grade hemorrhage was not associated with significant differences in unadjusted or adjusted risk of any adverse neurodevelopmental outcome compared with infants without hemorrhage. Compared with low-grade hemorrhage, severe hemorrhage was associated with decreased adjusted continuous cognitive (β, -3.91 [95% CI, -6.41 to -1.42]) and language (β, -3.19 [-6.19 to -0.19]) scores as well as increased odds of each adjusted categorical outcome except severe cognitive impairment (odds ratio [OR], 1.46 [0.74 to 2.88]) and mild language impairment (OR, 1.35 [0.88 to 2.06]).

CONCLUSIONS AND RELEVANCE: At 18 to 22 months, the neurodevelopmental outcomes of extremely low-gestational-age infants with low-grade periventricular-intraventricular hemorrhage are not significantly different from those without hemorrhage. Additional study at school age and beyond would be informative.

DOI10.1001/jamapediatrics.2013.866
Alternate JournalJAMA Pediatr
PubMed ID23460139
PubMed Central IDPMC3953349
Grant ListU10 HD021385 / HD / NICHD NIH HHS / United States
U10 HD053124 / HD / NICHD NIH HHS / United States
U10 HD053119 / HD / NICHD NIH HHS / United States
U10 HD021364 / HD / NICHD NIH HHS / United States
5T32HD060537-01 / HD / NICHD NIH HHS / United States
U10 HD027871 / HD / NICHD NIH HHS / United States
U10 HD068278 / HD / NICHD NIH HHS / United States
UG1 HD027851 / HD / NICHD NIH HHS / United States
M01 RR000080 / RR / NCRR NIH HHS / United States
U10 HD053089 / HD / NICHD NIH HHS / United States
U10 HD027856 / HD / NICHD NIH HHS / United States
U10 HD021373 / HD / NICHD NIH HHS / United States
U10 HD027880 / HD / NICHD NIH HHS / United States
U10 HD040521 / HD / NICHD NIH HHS / United States
U10 HD053109 / HD / NICHD NIH HHS / United States
UL1 TR001449 / TR / NCATS NIH HHS / United States
L40 HD067021 / HD / NICHD NIH HHS / United States
UG1 HD053089 / HD / NICHD NIH HHS / United States
U10 HD040461 / HD / NICHD NIH HHS / United States
T32 HD060537 / HD / NICHD NIH HHS / United States
U10 HD040689 / HD / NICHD NIH HHS / United States
U10 HD040492 / HD / NICHD NIH HHS / United States
U10 HD027904 / HD / NICHD NIH HHS / United States
U10 HD021397 / HD / NICHD NIH HHS / United States
UG1 HD034216 / HD / NICHD NIH HHS / United States
UL1 TR000439 / TR / NCATS NIH HHS / United States
UL1 TR000041 / TR / NCATS NIH HHS / United States
U10 HD027851 / HD / NICHD NIH HHS / United States
U10 HD034216 / HD / NICHD NIH HHS / United States
U10 HD036790 / HD / NICHD NIH HHS / United States
U10 HD040498 / HD / NICHD NIH HHS / United States
UG1 HD068278 / HD / NICHD NIH HHS / United States